This paper deals with the analysis of the costs, applied, for example, when treating specific diseases - an important aid in prioritizing the process of resource allocation. In our review, the specific disease is dementia caused by Alzheimer's disease. This paper aims to provide more information on the partial costs per patient that are calculated according to the aggregated data from publicly available sources as well as from the results of authors' own investigation. The University Hospital in Hradec Králové and the General Health Insurance Company of the Czech Republic participated in this research. The elementary research objective was to compare the costs per patient diagnosed early onset, to those of the patient diagnosed later. The Czech Republic lacks information regarding dementia. Therefore, these issues require attention. The methods used in this paper included time series analyses, methods of direct questioning, interviews with experts, and analyses of medical documentation. These methods were combined to exploit their particular advantages and to ensure the issues discussed, were covered. The investigation showed that the underpinning of patients with Alzheimer's disease at early onset is advantageous from an economic perspective, because the cost of outpatient care is much lower compared with that of inpatient care. The international comparisons of the volume of care provided should be approached with great caution. These are based solely on the facts of various expert estimates and are not usually supported by hard data. Yet, they still illustrate the overall view of our ability to take care of people with dementia. According to experts, care in the Czech Republic significantly lags behind the rest of developed Europe. While services are provided to 26% of people with dementia in Germany and 50% in France, the experts estimate that services are provided to only 10% of the population in the Czech Republic. If we were to offer a similar volume of services in the Czech Republic, to the same extent as the average in Europe, we would have to triple the existing capacities.

Biomedical Research Centrum University Hospital Hradec Králové Hradec Králové Czech Republic ; Center for Basic and Applied Research Faculty of Informatics and Management University of Hradec Králové Hradec Králové Czech Republic

Department of Economy Faculty of Informatics and Management University of Hradec Králové Hradec Králové Czech Republic

Department of Management University of Hradec Králové Hradec Králové Czech Republic

Department of Neurology Charles University Prague Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové Hradec Králové Czech Republic

Zobrazit více v PubMed

Wimo A, Gustavsson A, McDaid D, et al. The economic impact of dementia in Europe in 2008: cost estimates from the Eurocode project. Int J Geriatr Psychiatry. 2010;26:825–832. PubMed

Institute of Health Information and Statistics of the Czech Republic (Ústav zdravotnických a statistických informací) International Statistical Classification of Diseases and Related Health Problems. Institute of Health Information and Statistics of the Czech Republic; 2014. Available from: http://www.uzis.cz/cz/mkn/index.html.

Research Institute for Labor and Social Affairs (RILSA) Official Websites. Czech Republic; Prague: 2015. [Accessed: August 9, 2015]. [Online] Available from: http://www.vupsv.cz/?p=index&site=en.

Drummond MF, O’Brien BJ. Methods for the Economic Evaluation of Health Care Programs. 2nd ed. New York: Oxford Medical Publication; 1997.

General Health Insurance Company (Všeobecná zdravotní pojišťovna) Annual Report 2013. General Health Insurance Company; 2015. [online] Available from: http://www.vzp.cz/uploads/document/vzp-rocenka-2013.pdf. Czech.

Department of Neurology, University Hospital Hradec Králové 2014. [Accessed January 2, 2015]. Available from: http://www.fnhk.cz/neuro.

Hort J, O’Brien J, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer’s disease. Eur J Neurol. 2010;17:1236–1248. PubMed

Ministry of Health of the Czech Republic . Act No. 324/2014 Coll. Ministry of Health of the Czech Republic; Prague: 2015. [Accessed: April 4, 2015]. Available from: http://www.mzcr.cz/Legislativa/dokumenty/vyhlaska-c324/2014-sb-o-stanoveni-hodnot-boduvyse-uhrad-hrazenych-sluzeb-a_9871_11.html.

Czech statistical department . Results of Czech Health Accounts – 2000–2012. Prague: 2014. [Accessed: January 28, 2015]. Available from: https://www.czso.cz/csu/czso/vysledky-zdravotnickych-uctu-cr-2000-az-2012-efsq7vjwwi. Czech.

Zdraví a zdravotnictví . Homecare (Domácí péče) Czech Republic; Prague: 2000. [Accessed: February 14, 2015]. [Online] Available from: http://www.zdrav.cz/modules.php?op=modload&name=News&file=article&sid=1666&mode=thread&order=0.

Marešová P, Mohelská H, Kuča K. Cooperation Policy of Rare Diseases in the European Union. Procedia Soc Behav Sci. 2015;171:1302–1308.

Dlouhý M, Bartak M. Mental health financing in six eastern European countries. E M Ekon Manag. 2013;16(4):4–13.

Marešová P, Tomaskova H, Kuča K. The Use of Simulation Modelling in the Analysis of the Economic Aspects of Diseases in Old Age: EBES Conference Eurasia Business and Economics. 2014 In press.

Marešová P, Mohelská H, Kuča K. Economics Aspects of Ageing Population; WCBEM: 3rd World Conference on Business, Economics and Management; Rome: World Education Center; 2014. p. 6.

Mohelská H, Marešová P, Kuča K. Economic and Managerial Aspects of Alzheimer’s Disease in the Czech Republic. 3rd World Conference on Business, Economics and Management (BEM-2014) Procedia Economics and Finance. 2015;23:521–524.

Matl O, Holmerova I, Matlova M. Report on Dementia State in Czech Republic. Czech Alzheimer Society; Prague: 2014. [Accessed 2014]. Available from: http://www.alzheimer.cz/alzheimerova-choroba-v-cr/zverejnena-zprava-o-stavu-demence-2014/

Šoltés V, Gavurová B. The functionality comparison of the health care systems by the analytical hierarchy process method. E M Ekon Manag. 2014;17(3):100–117.

Šoltés M, Gavurová B. Identification of the functionality level of day surgery in Slovakia. J Econ. 2014;62(10):1031–1051.

Korabecny M. Pharmacotherapy of Alzheimer’s disease: current state and future perspectives. Frontiers in Drug Des Discov. 2014;6:702–738.

European Central Bank Euro foreign exchange reference rates. [Accessed: April 14, 2015]. [Online] Available from: https://www.ecb.europa.eu/stats/exchange/eurofxref/html/index.en.html.

The social and economic burden on family caregivers for older adults in the Czech Republic

The direct costs of multiple sclerosis-study in the Czech Republic

Costs of dementia in the Czech Republic

The economic burden of the care and treatment for people with Alzheimer's disease: the outlook for the Czech Republic

Treatment cost of narcolepsy with cataplexy in Central Europe

Patients' attitudes to the use of modern technologies in the treatment of diabetes

Use of the Internet as a prevention tool against cognitive decline in normal aging

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model